Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-–oxaliplatin regime...
Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-–oxaliplatin regimen in patients with metastatic colorectal cancer
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Polymorphisms in the metabolism, detoxification or DNA repair pathways have been proposed as potential predictors of response to 5-fluorouracil and oxaliplatin. We have studied the predictive value of a set of germline genetic polymorphisms in metastatic colorectal cancer patients treated with mFolfox-6.
A total of 72 patients, comprising 50 men...
Alternative Titles
Full title
Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-–oxaliplatin regimen in patients with metastatic colorectal cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_859743878
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_859743878
Other Identifiers
ISSN
1462-2416
E-ISSN
1744-8042
DOI
10.2217/pgs.10.196
